N90.1

Clinical Causes: Human papillomavirus (HPV) infection, especially high-risk HPV types Chronic irritation or inflammation of the vulvar area Immune system suppression, such as in individuals with HIV/AIDS or on immunosuppressive therapy Smoking history, which may increase vulnerability to cellular changes History of vulvar or genital skin conditions, like lichen sclerosus Multiple sexual partners or early sexual activity, which can facilitate HPV transmission

Key Symptoms: Persistent itching or irritation around the vulva Redness, soreness, or inflammation in the vulvar region Lesions or patches that may appear raised or flat Changes in skin color, such as white, pink, or red areas Discomfort or pain during sexual activity or urination Rarely, visible bumps or wart-like growths

Diagnosis Path: Medical history review focusing on symptoms and risk factors Physical examination of the vulvar area to identify suspicious lesions or patches Vulvar biopsy, where a small tissue sample is taken for laboratory analysis to confirm abnormal cell changes Histopathology examination to distinguish between different grades of dysplasia HPV testing may be performed to detect high-risk virus types Additional imaging or tests are generally not necessary unless there are concerns about invasive disease

Treatment Protocols: Surgical excision of affected tissue, often via local removal or laser therapy Topical treatments, such as imiquimod or 5-fluorouracil creams, to induce cellular changes and eliminate abnormal cells Regular follow-up examinations to monitor for recurrence or new lesions Management of underlying risk factors, such as quitting smoking or treating HPV infections Patient education on vulvar hygiene and self-examination to detect early signs of recurrence In some cases, consultation with a gynecologic oncologist may be recommended for ongoing management